Brief: Long-Term Survival Data From Longeveron's Elpis 1 Trial Presented At The 2023 Scientific Sessions Of The American Heart Association
Nov 11 (Reuters) - Longeveron Inc LGVN.O :
* LONG-TERM SURVIVAL DATA FROM LONGEVERON’S ELPIS 1 TRIAL
PRESENTED AT THE 2023 SCIENTIFIC SESSIONS OF THE AMERICAN HEART
ASSOCIATION
Source text for Eikon: ID:nGNX2wWWM4
Further company coverage: LGVN.O
((Reuters.Briefs@thomsonreuters.com;))